期刊文献+

核糖核酸干扰技术沉默大鼠心肌细胞核因子-κB p65表达的研究 被引量:1

Inhibition of nuclear-factor-κB p65 gene expression by RNA interference in rat cardiomyocytes
在线阅读 下载PDF
导出
摘要 目的:构建核因子-κB(nuclear factor-κB,NF-κB)p65亚基特异的核糖核酸干扰腺病毒表达载体,验证其对p65亚基的沉默效应。方法:设计针对大鼠NF-κB p65亚基的不同干扰序列,通过质粒将其导入腺病毒,感染大鼠心肌细胞(H9C2)。将感染后的心肌细胞通过RT-PCR方法和Western Blot方法检测各组NF-κB p65的基因水平表达和蛋白质水平表达。结果:成功构建了NF-κB p65亚基特异的RNAi腺病毒表达载体,获得高滴度的腺病毒液;RNAi腺病毒感染H9C2细胞后可以高效抑制NF-κB p65蛋白的表达。结论:RNAi技术能有效的沉默大鼠心肌细胞NF-κB p65的表达。 Objective:Construction of NF-κB p65 subunit-specific RNA interference adenovirus expression vector,Verify its effect on the p65 subunit of silence.Methods:Design different interference sequences for rat NF-κB p65 subunit,import it to adenovirus by plasmid,and then transfected the adenovirus into rat cardiomyocytes.The p65 gene silencing effect induced by the RNAi adenovirus was detected by Western blot and TRPCR in rat cardiomyocytes.Results:The NF-κB p65 subunit-specific RNAi adenovirus expression vectors was successfully constructed and the high titer adenovirus venom was obtained; The H9C2 cells infected by RNAi adenovirus can efficiently inhibit the NF-κB p65 protein expression.Conclusion:RNAi technology can effectively silence NF-κB p65 expression in rat cardiomyocytes.
出处 《心肺血管病杂志》 CAS 2014年第2期267-271,共5页 Journal of Cardiovascular and Pulmonary Diseases
基金 北京市自然科学基金(7112043)
关键词 核糖核酸干扰 核因子-ΚB 腺病毒 H9C2细胞 RNA interference NF-κB Adenovirus H9C2 cells
  • 相关文献

参考文献12

  • 1Ghosh S,May M J,Kopp EB,et al.NF-kappa B and Rel proteins:evolutionarily conserved mediato,rs of immune responses.Annu Rev Immunol,1998,16:225-260.
  • 2李丛锋,朱光发,王君,靳丽妍,闫树凤,吴春婷.针对核因子-κB小干扰RNA防治脓毒症急性肺损伤的实验研究[J].心肺血管病杂志,2012,31(3):333-337. 被引量:1
  • 3Livak K J,Schmittgen TD.Analysis of relative gene expression data using real-time quantitative PCR and the 2 (-Delta Delta C (T)) Method.Methods,2001,25:402-408.
  • 4Botto N,Sbrana S,Trianni G,et al.An increased platelet-leukocytes interaction at the culprit site of coronary artery occlusion in acute myocardial infarction:A pathogenic role for" no-reflow" phenomenon? Intern J Cardiology,2007,117:123-130.
  • 5杨秀秀,陈韵岱.无复流现象的预防与治疗[J].心肺血管病杂志,2008,27(1):55-59. 被引量:6
  • 6Sethi G,Sung B,Aggarwal BB.et al.Nuclear Factor-κB Activation:From Bench to Bedside.Exp Biol Med,2008,233:21-31.
  • 7Castanotto D,Rossi JJ.The promises and pitfalls of RNA-interference-based therapeutics.Nature,2009,457:426-433.
  • 8Elbashir SM,Lendeckel W,Tuschl T,et al.RNA interference is mediated by 21-and 22-nucleotide RNAs.Genes Dev,2001,15:188-200.
  • 9Suckau L,Fechner H,Chemaly E,et al.Long-term cardiac-targeted RNA interference for the treatment of heart failure restores cardiac function and reduces pathological hypertrophy.Circulation,2009,119:1241-1252.
  • 10Brummelkamp TR,Bemards R,Agami R.A system for stable expression of short interfering RNAs in mammalian cells.Science,2002,19:296:550-553.

二级参考文献50

共引文献5

同被引文献14

引证文献1

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部